Globe Life (NYSE:GL – Get Free Report) had its price objective hoisted by stock analysts at Truist Financial from $115.00 to $125.00 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has a “hold” rating on the stock. Truist Financial’s price target suggests a potential downside of 0.75% from the company’s current price.
GL has been the topic of several other research reports. JPMorgan Chase & Co. boosted their target price on Globe Life from $133.00 to $136.00 and gave the stock an “overweight” rating in a research report on Thursday. Raymond James boosted their target price on Globe Life from $138.00 to $160.00 and gave the stock a “strong-buy” rating in a research report on Monday, October 23rd. Morgan Stanley upped their price target on Globe Life from $131.00 to $132.00 and gave the stock an “equal weight” rating in a report on Wednesday, November 15th. StockNews.com upgraded Globe Life from a “hold” rating to a “buy” rating in a report on Thursday. Finally, Wells Fargo & Company upgraded Globe Life from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $122.00 to $137.00 in a report on Tuesday, October 31st. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Globe Life presently has an average rating of “Moderate Buy” and an average target price of $134.14.
View Our Latest Analysis on Globe Life
Globe Life Stock Up 0.8 %
GL opened at $125.94 on Friday. The business has a 50 day moving average price of $122.11 and a two-hundred day moving average price of $116.48. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.39. The company has a market cap of $11.85 billion, a PE ratio of 12.49 and a beta of 0.70. Globe Life has a 52 week low of $102.23 and a 52 week high of $125.98.
Globe Life (NYSE:GL – Get Free Report) last posted its quarterly earnings data on Wednesday, February 7th. The company reported $2.88 EPS for the quarter, beating the consensus estimate of $2.73 by $0.15. The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.40 billion. Globe Life had a return on equity of 24.75% and a net margin of 17.82%. The firm’s revenue was up 6.0% compared to the same quarter last year. During the same period in the prior year, the business earned $2.24 EPS. As a group, research analysts anticipate that Globe Life will post 11.45 EPS for the current year.
Insider Buying and Selling at Globe Life
In other Globe Life news, CAO Michael Shane Henrie sold 6,800 shares of the stock in a transaction on Wednesday, November 15th. The stock was sold at an average price of $117.57, for a total transaction of $799,476.00. Following the sale, the chief accounting officer now owns 700 shares in the company, valued at approximately $82,299. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Globe Life news, CAO Michael Shane Henrie sold 6,800 shares of the stock in a transaction on Wednesday, November 15th. The stock was sold at an average price of $117.57, for a total transaction of $799,476.00. Following the transaction, the chief accounting officer now owns 700 shares of the company’s stock, valued at approximately $82,299. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Jane Buchan sold 1,000 shares of the stock in a transaction on Tuesday, December 12th. The stock was sold at an average price of $124.50, for a total value of $124,500.00. Following the transaction, the director now directly owns 80,285 shares in the company, valued at approximately $9,995,482.50. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 55,303 shares of company stock worth $6,668,455. 4.33% of the stock is owned by insiders.
Institutional Investors Weigh In On Globe Life
Several institutional investors and hedge funds have recently added to or reduced their stakes in GL. First Trust Direct Indexing L.P. increased its position in Globe Life by 7.0% during the 3rd quarter. First Trust Direct Indexing L.P. now owns 2,985 shares of the company’s stock worth $325,000 after purchasing an additional 195 shares in the last quarter. Dean Investment Associates LLC increased its position in shares of Globe Life by 0.3% in the second quarter. Dean Investment Associates LLC now owns 35,125 shares of the company’s stock worth $3,850,000 after acquiring an additional 107 shares in the last quarter. IFM Investors Pty Ltd increased its position in shares of Globe Life by 5.6% in the second quarter. IFM Investors Pty Ltd now owns 18,112 shares of the company’s stock worth $1,985,000 after acquiring an additional 957 shares in the last quarter. Barclays PLC increased its position in shares of Globe Life by 48.0% in the third quarter. Barclays PLC now owns 254,116 shares of the company’s stock worth $27,632,000 after acquiring an additional 82,367 shares in the last quarter. Finally, Retirement Systems of Alabama acquired a new stake in shares of Globe Life in the second quarter worth $2,214,000. 80.04% of the stock is currently owned by institutional investors and hedge funds.
Globe Life Company Profile
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Read More
Receive News & Ratings for Globe Life Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Globe Life and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
